Last updated: 2 months ago
Pharming Group N.V. Acquires 92.7% of Abliva AB: Key Insights from Form 6-K Report
Pharming Technologies B.V. boosts ownership in Abliva AB to 92.7% with a cash offer. Explore details of this strategic acquisition and its implications for the biopharmaceutical market.